Update on Current Cancer-Based Clinical Trials
One of the University of Wisconsin Paul P. Carbone Comprehensive Cancer Center's greatest strengths is its involvement in groundbreaking clinical trials or research studies conducted to answer specific scientific questions about new ways to prevent, diagnose, detect and treat cancer.
We have more than 30 years experience in conducting cancer clinical trials. In 1979, the UW Comprehensive Cancer Center started conducting Phase I clinical trials, the first step in evaluating new treatments.
At that time, the UW Comprehensive Cancer Center was among the first six institutions in the country to be funded by the National Cancer Institute (NCI) to conduct such studies. Today, 18 institutions, including the UW Comprehensive Cancer Center are NCI-funded Phase 1 facilities.
Between 200 and 250 clinical trials are available for patient enrollment at the cancer center at any given time, including clinical trials conducted with community hospitals and regional cancer centers affiliated with the UW Comprehensive Cancer Center.
The key to clinical and translational research infrastructure of the UW Comprehensive Cancer Center are 15 work groups composed of clinical, translational and basic researchers and research staff. These work groups are dedicate to multidisciplinary cancer related clinical research focused on preventing, diagnosing and treating of disease specific areas of cancer. Each group prioritizes clinical trial opportunities based on current resources and select trials that have the potential to provide the best and most effective care for patients.
The clinical trials available at UW Comprehensive Cancer Center give your patients access to safe, cutting edge agents within a stringent oversight process to ensure safety and in adherence to federal and state guidelines. UW Comprehensive Cancer Center specialists work closely with you and your patients to provide comprehensive care.
For additional information about clinical trials, click on the links below: